| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.05M | 18.34M | 17.16M | 35.92M | 26.69M | 17.58M |
| Gross Profit | 7.28M | 8.30M | 8.00M | 9.98M | 10.31M | 10.35M |
| EBITDA | 5.60M | 2.22M | 1.12M | -1.93M | 4.08M | 5.07M |
| Net Income | 381.00K | -3.22M | -3.89M | -6.87M | -1.18M | -688.00K |
Balance Sheet | ||||||
| Total Assets | 72.15M | 60.47M | 62.18M | 68.58M | 105.70M | 108.03M |
| Cash, Cash Equivalents and Short-Term Investments | 994.00K | 582.00K | 953.00K | 843.00K | 6.79M | 4.19M |
| Total Debt | 0.00 | 43.96M | 45.68M | 55.40M | 84.94M | 90.32M |
| Total Liabilities | 69.00M | 63.38M | 62.00M | 64.86M | 95.30M | 96.92M |
| Stockholders Equity | -1.54M | -2.92M | 185.00K | 3.72M | 10.40M | 11.10M |
Cash Flow | ||||||
| Free Cash Flow | -784.00K | 1.41M | 2.75M | -3.88M | 4.77M | 845.00K |
| Operating Cash Flow | -41.00K | 1.94M | 3.71M | -3.60M | 4.89M | 1.29M |
| Investing Cash Flow | 5.23M | -530.00K | -958.00K | -281.00K | -123.00K | -450.00K |
| Financing Cash Flow | -4.70M | -2.13M | -2.48M | -2.06M | -2.42M | -1.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $2.13B | 21.16 | 9.94% | 1.80% | 23.74% | -18.99% | |
73 Outperform | $1.01B | 38.53 | 10.87% | ― | 29.89% | 10.33% | |
61 Neutral | $443.26M | 1.32 | ― | ― | 0.74% | ― | |
54 Neutral | $594.43M | -11.05 | -44.33% | ― | 34.99% | -68.73% | |
52 Neutral | $2.90B | -9.28 | -214.33% | ― | 3.93% | -42.22% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
41 Neutral | $5.31M | -1.82 | ― | ― | 121.82% | 52.08% |
At its 2025 Annual Meeting of Shareholders held on January 5, 2026 in Atlanta, Regional Health Properties, Inc. shareholders elected four directors representing common stockholders and three additional directors representing preferred stockholders in the Series B and Series D classes, all to serve until the 2026 annual meeting. Common shareholders also approved an amended and restated 2023 Omnibus Incentive Compensation Plan, endorsed executive compensation on an advisory basis, expressed a preference to hold Say-on-Pay votes every three years, and ratified the appointment of Cherry Bekaert, LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, reinforcing continuity in the company’s governance, incentive structures, and audit oversight.
The most recent analyst rating on (RHEP) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Regional Health Properties stock, see the RHEP Stock Forecast page.
On December 30, 2025, Regional Health Properties, Inc. convened its 2025 Annual Meeting of Shareholders but adjourned it without conducting any business because a quorum of outstanding shares was not present or represented by proxy. The company will reconvene the meeting on January 5, 2026, in Atlanta to vote on the previously disclosed proposals, keeping November 14, 2025 as the record date, and will use the adjournment period to solicit additional proxies, with all prior proxies remaining valid unless revoked and no changes made to the proposals or related proxy materials.
The most recent analyst rating on (RHEP) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Regional Health Properties stock, see the RHEP Stock Forecast page.